Caterina Musolino

Messina, 98121, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 154 publications

Editorial expression of concern: Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock.

Editorial expression of concern: Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: September 06, 2024

Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.

Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.

Journal: NEJM evidence
Published: February 06, 2024

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.

Journal: Annals of hematology
Published: November 13, 2023

Critical Role of Aquaporins in Cancer: Focus on Hematological Malignancies.

Critical Role of Aquaporins in Cancer: Focus on Hematological Malignancies.

Journal: Cancers
Published: July 22, 2022

Circulating Tumour Cells, Cell Free DNA and Tumour-Educated Platelets as Reliable Prognostic and Management Biomarkers for the Liquid Biopsy in Multiple Myeloma.

Circulating Tumour Cells, Cell Free DNA and Tumour-Educated Platelets as Reliable Prognostic and Management Biomarkers for the Liquid Biopsy in Multiple Myeloma.

Journal: Cancers
Published: July 21, 2022

Mast Cells and Vitamin D Status: A Clinical and Biological Link in the Onset of Allergy and Bone Diseases.

Mast Cells and Vitamin D Status: A Clinical and Biological Link in the Onset of Allergy and Bone Diseases.

Journal: Biomedicines
Published: July 07, 2022

Cold Atmospheric Plasma Targeting Hematological Malignancies: Potentials and Problems of Clinical Translation.

Cold Atmospheric Plasma Targeting Hematological Malignancies: Potentials and Problems of Clinical Translation.

Journal: Antioxidants (Basel, Switzerland)
Published: July 05, 2022

Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach?

Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach?

Journal: Antioxidants (Basel, Switzerland)
Published: May 26, 2022

Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma.

Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma.

Journal: Cancers
Published: April 19, 2022

Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy.

Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy.

Journal: Biomolecules
Published: March 16, 2022

Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma.

Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma.

Journal: Cancers
Published: March 14, 2022

Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies.

Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies.

Journal: Cells
Published: February 11, 2022
Showing 1-12 of 154

Last Updated: 09/26/2026